Neuroprotection targeted to oxidative stress and induced mitochondrial dysfunction and ferroptosis in ischemic stroke
Schematic illustration of neuroprotection targeted to oxidative stress and induced mitochondrial dysfunction and ferroptosis in ischemic stroke. (A) NMDAR and AMPAR inhibitors targeted to reduce calcium overload. (B) ROS scavenger antioxidant and Nrf2 inducer in regulating the Nrf2 pathway under oxidative stress conditions. Disruption of the Nrf2-Keap1 association is mediated by free radicals, or inducers of Nrf2, and leads to a diminished rate of proteolysis, thereby enhancing the nuclear accumulation of Nrf2 in the nucleus. Nrf2 binds with AREs in the promoter region of its target genes and induces nuclear-encoded mitochondrial proteins and GPX4, resulting in an adaptive response. (C) Mitochondrial homeostasis is maintained through balanced biogenesis of new mitochondria, mitochondrial fission, and fusion. The mitochondrial shape is fundamental to mitochondrial (metabolic) activity. The efficiency of ATP production is increased, and the exchange of matrix content is favored in fused organelles. In contrast, fragmented organelles produce more reactive oxygen species (ROS) and are efficiently cleared by mitophagy. Mitochondrial fission is a hallmark of the early steps of apoptosis. D. The indicated pathways regulating ferroptosis sensitivity.
Publication
Neuroprotective Strategies for Stroke by Natural Products: Advances and Perspectives (2023) Aifen Liu, et al. Curr Neuropharmacol. 2023 Sep 1;21(11):NA. Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | Nrf2 | NRF2 | ncbigene_synonym | GABPA | 2551 |
| Homo sapiens | Primates | Nrf2 | NRF2 | ncbigene_synonym | NFE2L2 | 4780 |
| Homo sapiens | Primates | NMDAR | GRIN | famplex_relations | GRIN1 | 2902 |
| Homo sapiens | Primates | NMDAR | GRIN | famplex_relations | GRIN2A | 2903 |
| Homo sapiens | Primates | NMDAR | GRIN | famplex_relations | GRIN2B | 2904 |
| Homo sapiens | Primates | NMDAR | GRIN | famplex_relations | GRIN2C | 2905 |
| Homo sapiens | Primates | NMDAR | GRIN | famplex_relations | GRIN2D | 2906 |
| Homo sapiens | Primates | NMDAR | GRIN | famplex_relations | GRIN3A | 116443 |
| Homo sapiens | Primates | NMDAR | GRIN | famplex_relations | GRIN3B | 116444 |
| Homo sapiens | Primates | Nat | NAT | ncbigene_synonym | BRD2 | 6046 |
| Homo sapiens | Primates | Drp-1 | DRP-1 | ncbigene_synonym | CRMP1 | 1400 |
| Homo sapiens | Primates | Drp-1 | DRP-1 | ncbigene_synonym | DAPK2 | 23604 |
| Homo sapiens | Primates | SOD | SOD | ncbigene_synonym | SOD1 | 6647 |
| Homo sapiens | Primates | SOD | SOD | famplex_relations | SOD2 | 6648 |
| Homo sapiens | Primates | SOD | SOD | famplex_relations | SOD3 | 6649 |
| Homo sapiens | Primates | keap1 | KEAP1 | ncbigene_symbol | KEAP1 | 9817 |
| Homo sapiens | Primates | PUFA | PUFA | ncbigene_synonym | PUM3 | 9933 |
| Homo sapiens | Primates | LPCAT3 | LPCAT3 | ncbigene_symbol | LPCAT3 | 10162 |
| Homo sapiens | Primates | GPX4 | GPX4 | ncbigene_symbol | GPX4 | 2879 |
| Homo sapiens | Primates | LOX | LOX | ncbigene_symbol | LOX | 4015 |
| Homo sapiens | Primates | ACSL4 | ACSL4 | ncbigene_symbol | ACSL4 | 2182 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| inhibitors | inhibitors | inhibitor | chebi:35222 | |
| inhibitors | inhibitors | inhibitor | chebi:35222 | |
| Ca2+ | Ca2+ | Ca(2+) | chebi:29108 | |
| Nat | NAT | chebi:82508 | ||
| GSSG | GSSG | (2S,2'S)-5,5'-[disulfanediylbis({(2R)-3-[(carboxymethyl)amino]-3-oxopropane-1,2-diyl}imino)]bis(2-amino-5-oxopentanoic acid) | chebi:17858 | |
| PUFA | PUFA | chebi:76567 | ||
| GSH | GSH | L-gamma-glutamyl-L-cysteinylglycine | chebi:16856 | |
| Nucleus | nucleus | nucleus | chebi:33252 | |
| Cystine | cystine | cystine | chebi:17376 | |
| Fe2+ | Fe2+ | iron(2+) | chebi:29033 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|